1. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer
   Kazuhisa Kitami et al, 2020, IJMS CrossRef
2. Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal Dissemination
   Kazumasa Mogi et al, 2021, Cancers CrossRef
3. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
   Sabrina J. Ritch et al, 2022, Front. Endocrinol. CrossRef
4. The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
   Aiping Zheng et al, 2022, Front. Immunol. CrossRef
5. Friend and foe: the regulation network of ascites components in ovarian cancer progression
   Zhe Geng et al, 2022, J. Cell Commun. Signal. CrossRef
6. Proteomic study of mesothelial and endothelial cross-talk: key lessons
   Juan Manuel Sacnun et al, 2023, Expert Review of Proteomics CrossRef
7. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
   Jacek R. Wilczyński et al, 2023, Front. Oncol. CrossRef
8. Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells via Abating HIF-1α-Wnt/β-Catenin Signaling Pathway
   Xin Tu et al, 2023, ACAMC CrossRef